Journey Medical Corp (NASDAQ:DERM) traded at $5.42 at last check on current trade day and made a downward move of -12.16% on its previous day’s price.
Looking at the stock we see that its previous close was $6.17 and the beta (5Y monthly) reads 0.929 with the day’s price range being $5.0 – $6.335. In terms of its 52-week price range, DERM has a high of $8.11 and a low of $2.85. The company’s stock has lost about -17.00% over that past 30 days.
Journey Medical Corp has a market cap of $120.55 million and is expected to release its quarterly earnings report on 2024-Aug-12. Estimates by analysts give the company expected earnings per share (EPS) of -0.15, with the EPS growth for the year raised at -0.99 for current year and -0.99 for next year.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at 14.46M, with a low of 14.2M and a high of 14.9M. According to analyst consensus estimates figures, the company’s yearly revenue forecast for current year is expected to hit 57.1M, or -27.90% down from figures reported last year.
On the other hand, looking at the outlook for the DERM stock, short term indicators assign the stock an average of 50% Buy, while medium term indicators assign it an average of 50% Buy.
Based on estimates by 1 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Journey Medical Corp (DERM) stock as a Hold, while 1 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is -8.33% off its SMA20 and -2.09% from its 50-day simple moving average. The RSI (14) is pointing at 44.29 while the volatility over the past week is 6.23% and jumps to 8.24% over the past one month. The beta value is 0.92, while the average true range (ATR) is currently pointing at 0.51.
Coming back to Journey Medical Corp (NASDAQ:DERM), we note that the average 3-month trading volume was 70.36K, while that of the preceding 10-day period stands at 0.13 million. Current shares outstanding are 13.32 million.
The insiders hold 51.56% of the company’s shares while institutions hold 11.48%. The data shows that short shares as of 2024-10-15, stood at 76691.0 at a short ratio of 1.28. This represents a 177.00 short interest in shares outstanding on 2024-10-15. Shares short fall in October from the previous month at 79393.0. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock -5.90% down in year-to-date price movement.
